Resultados de la búsqueda 291-300 of 14349 for Nephritic syndrome

  1. Cirugía - Ensayos clínicos - Mayo Clinic

    ... disease). This is an investigational study. Radiation therapy is delivered using FDA-approved and commercially available methods. The study doctor can ...

  2. Cirugía - Ensayos clínicos - Mayo Clinic

    ... disease). This is an investigational study. Radiation therapy is delivered using FDA-approved and commercially available methods. The study doctor can ...

  3. Cirugía - Ensayos clínicos - Mayo Clinic

    ... disease). This is an investigational study. Radiation therapy is delivered using FDA-approved and commercially available methods. The study doctor can ...

  4. Síndrome del corazón izquierdo hipoplásico - Médicos y departamentos - Mayo Clinic

    Todd and Karen Wanek Family Program for Hypoplastic Left Heart Syndrome. Mostrar más productos y servicios de Mayo Clinic. U.S. News & World Report reconoce a ...

  5. Cirugía - Ensayos clínicos - Mayo Clinic

    The purpose of this study is to determine whether there is an increase in the time of a first occurrence of either: local recurrence, leptomeningeal disease, or ...

  6. Tumor cerebral

    Lynch syndrome management. Mayo Clinic; 2021. Hügel M, et al. Long-term survival in patients with brain metastases — Clinical characterization of a rare ...

  7. Cirugía - Ensayos clínicos - Mayo Clinic

    ... disease). This is an investigational study. Radiation therapy is delivered using FDA-approved and commercially available methods. The study doctor can ...

  8. Neurología - Ensayos clínicos - Mayo Clinic

    Jacksonville, Fla. The primary purpose of this study is to create a Mayo Clinic repository for neurodegenerative disorders such as Parkinson's disease (PD), ...

  9. Neurología - Ensayos clínicos - Mayo Clinic

    Jacksonville, Fla. The primary purpose of this study is to create a Mayo Clinic repository for neurodegenerative disorders such as Parkinson's disease (PD), ...

  10. Ensayos clínicos - Neurología

    ... syndrome, and all-cause mortality 6 months after the event, and (2) improves stroke outcomes at 3 months in patients who experienced an ischemic stroke. A ...